Atossa Therapeutics (DE:YAG2)
FRANKFURT:YAG2
Holding DE:YAG2?
Track your performance easily

Atossa Therapeutics (YAG2) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Atossa Therapeutics’s (YAG2) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Atossa Therapeutics is a Sell.
Atossa Therapeutics’s (YAG2) 20-Day exponential moving average is 1.08, while Atossa Therapeutics’s (YAG2) share price is €1.144, making it a Buy.
Atossa Therapeutics’s (YAG2) 50-Day exponential moving average is 1.15, while Atossa Therapeutics’s (YAG2) share price is €1.144, making it a Sell.

Atossa Therapeutics (YAG2) Pivot Points

Nov 14, 2024, 07:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.02
1.04
1.10
1.13
1.19
1.22
1.28
Fibonacci
1.04
1.08
1.10
1.13
1.17
1.19
1.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atossa Therapeutics (YAG2) Moving Averages

Nov 14, 2024, 07:16 AM
Period
Simple
Exponential
MA5
1.07Buy
1.10Buy
MA10
1.07Buy
1.07Buy
MA20
1.04Buy
1.08Buy
MA50
1.21Sell
1.15Sell
MA100
1.26Sell
1.16Sell
MA200
0.99Buy
1.02Buy
Atossa Therapeutics’s (YAG2) 10-Day exponential moving average is 1.07, while Atossa Therapeutics’s (YAG2) share price is €1.144, making it a Buy.
Atossa Therapeutics’s (YAG2) 100-Day exponential moving average is 1.16, while Atossa Therapeutics’s (YAG2) share price is €1.144, making it a Sell.
Atossa Therapeutics’s (YAG2) stock price is €1.144 and Atossa Therapeutics’s (YAG2) 50-day simple moving average is 1.21, creating a Sell signal.
Atossa Therapeutics’s (YAG2) stock price is €1.144 and Atossa Therapeutics’s (YAG2) 100-day simple moving average is 1.26, creating a Sell signal.
Atossa Therapeutics’s (YAG2) stock price is €1.144 and Atossa Therapeutics’s (YAG2) 200-day simple moving average is 0.99, creating a Buy signal.

Atossa Therapeutics (YAG2) Technical Indicators

Nov 14, 2024, 07:16 AM
Name
Value
Implied Action
RSI (14)
54.24
Neutral
STOCH (9,6)
68.75
Neutral
STOCHRSI (14)
70.95
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
20.95
Neutral
Williams %R
-17.90
Sell
CCI (14)
158.51
Sell
ATR (14)
0.05
-
Ultimate Oscillator
64.72
Neutral
ROC
18.92
Buy
Atossa Therapeutics’s (YAG2) Relative Strength Index (RSI) is 54.24, creating a Neutral signal.
Atossa Therapeutics’s (YAG2) Trend Strength Indicator (ADX) is 20.95, creating a Neutral signal.
Atossa Therapeutics’s (YAG2) Commodity Channel Index (CCI) is 158.51, creating a Sell signal.
Atossa Therapeutics’s (YAG2) Price Rate of Change (ROC) is 18.92, creating a Buy signal.

FAQ

Is YAG2 a Buy, Hold, or Sell?
Based on YAG2’s technical indicators, YAG2 is a Buy.
    What is YAG2’s RSI (14)?
    YAG2’s RSI (14) is 54.24, which suggests YAG2 is a Neutral.
      What is YAG2’s MACD?
      YAG2’s MACD is -0.02, which suggests YAG2 is a Sell.
        What is YAG2’s 5-day moving average?
        YAG2’s 5-day moving average is 1.07, which suggests YAG2 is a Buy.
          What is YAG2’s 20-day moving average?
          YAG2 20-day moving average is 1.04, which suggests YAG2 is a Buy.
            What is YAG2’s 50-day moving average?
            YAG2’s 50-day moving average is 1.21, which suggests YAG2 is a Sell.
              What is YAG2’s 200-day moving average?
              YAG2’s 200-day moving average is 0.99, which suggests YAG2 is a Buy.
                What is YAG2’s Williams % R (14)?
                YAG2’s Williams % R (14) is -17.90, which suggests YAG2 is a Sell.
                  What is YAG2’s CCI (14)?
                  YAG2’s CCI (14) is 158.51, which suggests YAG2 is a Sell.
                    What is the share price of Atossa Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis